California Senate Bill 306 Sexually Transmitted Disease Testing

As a reminder, effective January 1, 2022, California Senate Bill (SB) 306 requires healthcare service plans and insurers to provide coverage for home test kits for sexually transmitted diseases (STD), including the test kit and any laboratory costs of processing the kit that are deemed medically necessary or appropriate. The kit must be ordered directly by a clinician or furnished through a standing order for patient use based on clinical guidelines and individual patient health needs at zero-dollar cost share to Anthem Blue Cross members.

 

For purposes of this bill, home test kit means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force that has been CLIA-waived, FDA-cleared or -approved, or developed by a laboratory in accordance with established regulations and quality standards to allow individuals to self-collect specimens for STDs, including HIV, remotely at a location outside of a clinical setting.

 

If you have any questions, contact your assigned Provider Experience associate, or visit the Contact Us page on our provider website for up-to-date contact information.

CABC-COMM-000861-22